Pashine Achal, Busch Robert, Belmares Michael P, Munning Jason N, Doebele Robert C, Buckingham Megan, Nolan Gary P, Mellins Elizabeth D
Department of Pediatrics, Stanford University, Stanford, California 94305, USA.
Immunity. 2003 Aug;19(2):183-92. doi: 10.1016/s1074-7613(03)00200-0.
HLA-DM (DM) edits major histocompatibility complex class II (MHCII)-bound peptides in endocytic compartments and stabilizes empty MHCII molecules. Crystal structures of DM have revealed similarity to MHCII but not how DM and MHCII interact. We used mutagenesis to map a MHCII-interacting surface on DM. Mutations on this surface impair DM action on HLA-DR and -DP in cells and DM-dependent peptide loading in vitro. The orientation of DM and MHCII predicted by these studies guided design of soluble DM and DR molecules fused to leucine zippers via their beta chains, resulting in stable DM/DR complexes. Peptide release from the complexes was fast and only weakly sequence dependent, arguing that DM diminishes the selectivity of the MHCII groove. Analysis of soluble DM action on soluble DR/peptide complexes corroborates this conclusion.
HLA-DM(DM)在内吞小室中编辑与主要组织相容性复合体II类(MHCII)结合的肽,并稳定空载的MHCII分子。DM的晶体结构显示出与MHCII相似,但未揭示DM与MHCII如何相互作用。我们利用诱变技术绘制了DM上与MHCII相互作用的表面。该表面上的突变会损害DM在细胞中对HLA-DR和-DP的作用以及体外DM依赖性肽装载。这些研究预测的DM和MHCII的方向指导了通过其β链与亮氨酸拉链融合的可溶性DM和DR分子的设计,从而产生稳定的DM/DR复合物。肽从复合物中的释放很快且仅弱依赖于序列,这表明DM降低了MHCII凹槽的选择性。对可溶性DM对可溶性DR/肽复合物作用的分析证实了这一结论。